About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in California | 691 Studies

Clinical Trials MelanomaCalifornia

Melanoma Clinical Trials in California

Find 691 clinical trials for melanoma near California. Connect with research centers in your area.

All Melanoma trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 521-540 of 691 trials

CompletedStudy to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the BrainThis is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118436) and Trametinib (GSK1120212) combination therapy in subject with BRAF mutation-positive melanoma…NCT02039947·Birmingham, Alabama and 46 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of MGC026 in Participants With Advanced Solid TumorsThe study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or…NCT06242470·Los Angeles, California and 11 others

UnknownEfficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) MutationThis open-label phase II trial studies how well niraparib works in treating patients with advanced, metastatic melanoma with the homologous recombination (HR) pathway gene…NCT03925350·San Francisco, California

CompletedS0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryRATIONALE: Thalidomide may stop the growth of melanoma by blocking blood flow to the tumor.NCT00104988·Anchorage, Alaska and 131 others

TerminatedIpilimumab and Local Radiation for Selected Solid TumorsThis pilot phase 1-2 trial studies the side effects and best of dose ipilimumab when given together with local radiation therapy and to see how well it works in treating patients…NCT01769222·Stanford, California

CompletedVaccine Therapy in Treating Patients With Unresected Stage III or Stage IV MelanomaRATIONALE: Vaccines made from a person's white blood cells and a donor's tumor cells may help the body build an effective immune response to kill tumor cells.NCT00107159·Los Angeles, California

CompletedA Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesThis is a Phase 1/1b, multicenter, open-label, dose-escalation, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and…NCT04772989·Los Angeles, California and 21 others

CompletedA Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerThe purpose of this study is to evaluate if the treatment with NEO-PV-01 + adjuvant in combination with nivolumab is safe and useful for patients with certain types of cancer.NCT02897765·Duarte, California and 8 others

Active not recruitingA Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV MelanomaThis is a Phase II, open-label, single arm study.NCT03999749·Los Angeles, California and 3 others

RecruitingA Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsThis study is a Phase 1/2, first-in-human, open-label, clinical trial to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of HMBD-501 in patients with…NCT06956690·La Jolla, California and 6 others

CompletedPhase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced MelanomaCMP-001-002 is a Phase 1b study of CMP-001 administered to participants with advanced melanoma who are either receiving pembrolizumab, or who have previously received an…NCT03084640·Los Angeles, California and 3 others

TerminatedGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersThe purpose of this study is to evaluate the safety of the investigational product GL-ONC1.NCT02714374·La Jolla, California

CompletedA Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsStudy CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in combination with lorigerlimab (MGD019).NCT05293496·Los Angeles, California and 9 others

CompletedVEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryThis phase II trial is studying how well VEGF Trap works in treating patients with recurrent stage III or stage IV melanoma that cannot be removed by surgery.NCT00450255·Duarte, California

TerminatedHD IL-2 + Ipilimumab in Patients With Metastatic MelanomaPhase IV, open-label, randomized, two-arm, multi-center study in patients with metastatic melanoma who are treatment naïve or have previously received a single non-immunologic…NCT01856023·Tucson, Arizona and 11 others

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 744 others

Active not recruitingTalimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV MelanomaThis phase II trial studies how well talimogene laherparepvec and pembrolizumab work in treating patients with stage III-IV melanoma.NCT02965716·Mobile, Alabama and 19 others

CompletedGranulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in MelanomaThe study is an open-label, single arm single Center Phase II study to evaluate the safety and efficacy of the combination of Granulocyte Macrophage-Colony Stimulating Factor…NCT01363206·San Francisco, California and 1 other

TerminatedITIL-168 in Advanced MelanomaDELTA-1 is a phase 2 clinical trial to evaluate the efficacy and safety of ITIL-168 in adult subjects with advanced melanoma who have previously been treated with a PD-1 inhibitor.NCT05050006·La Jolla, California and 21 others

Active not recruitingA Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid TumoursThe purpose of this study is to determine the appropriate dosage, safety and effectiveness of the study drug, IPN01194 in adults with advanced solid tumours.NCT06305247·Los Angeles, California and 11 others

PreviousPage 27 of 35Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma